LMR Partners’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-71,100
| Closed | -$829K | – | 1050 |
|
|
2024
Q4 | $829K | Hold |
71,100
| – | – | 0.01% | 421 |
|
|
2024
Q3 | $1.46M | Buy |
71,100
+18,533
| +35% | +$381K | 0.01% | 297 |
|
|
2024
Q2 | $1.18M | Buy |
52,567
+22,609
| +75% | +$506K | 0.01% | 303 |
|
|
2024
Q1 | $824K | Buy |
29,958
+2,468
| +9% | +$67.9K | 0.01% | 314 |
|
|
2023
Q4 | $838K | Sell |
27,490
-2,800
| -9% | -$85.4K | 0.01% | 307 |
|
|
2023
Q3 | $958K | Buy |
30,290
+11,600
| +62% | +$367K | 0.01% | 321 |
|
|
2023
Q2 | $762K | Buy |
+18,690
| New | +$762K | 0.01% | 344 |
|
|
2023
Q1 | – | Sell |
-13,192
| Closed | -$460K | – | 1121 |
|
|
2022
Q4 | $460K | Sell |
13,192
-10,816
| -45% | -$377K | 0.01% | 875 |
|
|
2022
Q3 | $1.34M | Buy |
24,008
+9,856
| +70% | +$551K | 0.02% | 630 |
|
|
2022
Q2 | $733K | Sell |
14,152
-3,497
| -20% | -$181K | 0.01% | 830 |
|
|
2022
Q1 | $1.28M | Buy |
+17,649
| New | +$1.28M | 0.01% | 713 |
|